3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
3
Prostatic Neoplasms
2
Odontogenic Cysts
2
Liver Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Carcinoma, Hepatocellular
1
Cancer Diagnosis
1
Anus Neoplasms
1
Interventions
Cisplatin
141
Radiotherapy
115
Cetuximab
95
Docetaxel
69
Radiotherapy, Intensity-Modulated
55
Carboplatin
47
pembrolizumab
46
Surveys and Questionnaires
46
Paclitaxel
41
Fluorouracil
39
Radiation
29
Blood Specimen Collection
27
Drug Therapy
26
Erlotinib Hydrochloride
23
Nivolumab
21
Surgical Procedures, Operative
17
Standard of Care
16
Magnetic Resonance Spectroscopy
16
Radiosurgery
14
Pemetrexed
14
Gemcitabine
14
Everolimus
13
Celecoxib
13
durvalumab
12
Low-Level Light Therapy
12
Immunohistochemistry
12
Cyclophosphamide
12
Capecitabine
12
Amifostine
12
Chemoradiotherapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Head and Neck Neoplasms
×
Radionuclide Imaging
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled